NCT03869216Completed
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
Source: ClinicalTrials.gov · Last updated 29 Dec 2025
Brief summary (registry, in English)
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 161 (actual)
- First submitted
- 4 Mar 2019
- Start date
- 17 Aug 2020
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Xavier University of Louisiana.
- Diseases
- Prostate cancer
- NCT number
- NCT03869216
What you commit to
- Study type: Interventional
- Participants enrolled: 161
- From 17 Aug 2020 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- Receiving care at the clinical sites
- Identify as African American male
- Ages 40-69 years old
- Patient Exclusion Criteria:
- Personal history of prostate cancer at the time of consent
- Cognitive impairment that would interfere with participation in the study
- Unable to complete any aspect of the intervention within the specified time limit
Age in the registry: 40 years to 69 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tulane Medical Center Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.